Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-02-13 5:02 pm Sale | 13G | CONMED CORPORATION CNMD | VANGUARD GROUP INC | 3,420,011 11.12% | -3,487 (-0.10%) | View |
2024-02-12 9:42 pm Sale | 13G | CONMED CORPORATION CNMD | EARNEST PARTNERS LLC | 2,345,697 7.6% | -56,655 (-2.36%) | View |
2024-02-09 5:49 pm Purchase | 13G | CONMED CORPORATION CNMD | Capital Research Global Investors | 2,757,108 9% | 564,714 (+25.76%) | View |
2024-01-22 2:03 pm Purchase | 13G | CONMED CORPORATION CNMD | BlackRock Inc. BLK | 5,031,016 16.4% | 108,048 (+2.19%) | View |
2023-02-13 3:32 pm Purchase | 13G | CONMED CORPORATION CNMD | Capital Research Global Investors | 2,192,394 7.2% | 1,474,094 (+205.22%) | View |
2023-02-13 3:23 pm Sale | 13G | CONMED CORPORATION CNMD | Champlain Investment Partners LLC | 1,275,910 4.19% | -218,725 (-14.63%) | View |
2023-02-13 08:38 am Purchase | 13G | CONMED CORPORATION CNMD | EARNEST PARTNERS LLC | 2,402,352 7.9% | 740,560 (+44.56%) | View |
2023-02-09 11:15 am Purchase | 13G | CONMED CORPORATION CNMD | VANGUARD GROUP INC | 3,423,498 11.23% | 254,850 (+8.04%) | View |
2023-01-26 08:52 am Unchanged | 13G | CONMED CORPORATION CNMD | BlackRock Inc. BLK | 4,922,968 16.2% | 0 (Unchanged) | View |
2023-01-20 3:00 pm Purchase | 13G | CONMED CORPORATION CNMD | BlackRock Inc. BLK | 4,922,968 16.2% | 294,840 (+6.37%) | View |
2022-07-11 3:10 pm Purchase | 13G | CONMED CORPORATION CNMD | EARNEST PARTNERS LLC | 1,661,792 5.6% | 184,530 (+12.49%) | View |
2022-03-10 2:13 pm Sale | 13G | CONMED CORPORATION CNMD | EARNEST PARTNERS LLC | 1,477,262 5% | -42,061 (-2.77%) | View |
2022-02-14 12:31 pm Sale | 13G | CONMED CORPORATION CNMD | EARNEST PARTNERS LLC | 1,519,323 5.2% | -56,013 (-3.56%) | View |
2022-02-11 11:40 am Sale | 13G | CONMED CORPORATION CNMD | Champlain Investment Partners LLC | 1,494,635 5.11% | -197,379 (-11.67%) | View |
2022-02-09 3:43 pm Purchase | 13G | CONMED CORPORATION CNMD | VANGUARD GROUP INC | 3,168,648 10.83% | 166,260 (+5.54%) | View |
2022-01-27 11:00 am Unchanged | 13G | CONMED CORPORATION CNMD | BlackRock Inc. BLK | 4,628,128 15.8% | 0 (Unchanged) | View |
2022-01-25 3:03 pm Purchase | 13G | CONMED CORPORATION CNMD | BlackRock Inc. BLK | 4,628,128 15.8% | 150,327 (+3.36%) | View |
2021-02-16 4:40 pm Purchase | 13G | CONMED CORPORATION CNMD | EARNEST PARTNERS LLC | 1,575,336 5.5% | 1,575,336 (New Position) | View |
2021-02-16 3:28 pm Sale | 13G | CONMED CORPORATION CNMD | Capital Research Global Investors | 718,300 2.5% | -1,438,351 (-66.69%) | View |
2021-02-12 1:29 pm Purchase | 13G | CONMED CORPORATION CNMD | Champlain Investment Partners LLC | 1,692,014 5.92% | 566,474 (+50.33%) | View |